Home > PB Ratio > CONCORD BIOTECH

CONCORD BIOTECH
PB (Price/Book ) Ratio

The Current P/B Ratio of CONCORD BIOTECH is 11.89.

Share Price ₹2,060.3Jun 12,2025
Market Cap ₹21,550.2 Cr
Book Value₹1,812.7 CrMar2025 - Consolidated Results
Price/Book 11.89xCalculated as MarketCap/Book Value
Explore Stock Analytics
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PB (Price/Book ) ratio of CONCORD BIOTECH

Price-to-Book ratio, P/B Multiple, or P/B Ratio is an important valuation multiple that is defined as:

P/B = Market Capitalization / Book Value

or, using per-share numbers:

P/B = Stock Price / Book Value Per Share

Applying the above formula, P/B ratio of CONCORD BIOTECH is calculated as :

Current Market Cap [ ₹21,550.2 Cr] as on Jun 12,2025

(/) Book Value [ ₹1,812.7 Cr] based on Mar2025 - Consolidated Results

(=) P/B Ratio [ 11.89x ]

P/B Ratio indicates 'the multiple of book value' investors are willing to pay to own one share of the company.

Thus, for CONCORD BIOTECH , the investors are currently willing to pay '11.89 times book value' to own 1 share of the company.

PB Multiples are one of the most widely used valuation multiple in industry.

Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.

In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CONCORD BIOTECH !

The chart below summarizes the trend in P/B Ratio of CONCORD BIOTECH over the last five years.

Historical PB (Price/Book ) ratio chart of CONCORD BIOTECH


PB Ratio Performance Analysis for CONCORD BIOTECH

- CONCORD BIOTECH 's latest p/b ratio is 11.89x.

- CONCORD BIOTECH 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 2.09x.

- CONCORD BIOTECH 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, CONCORD BIOTECH 's p/b ratio peaked in Mar2024 at 10.43x.

- CONCORD BIOTECH 's p/b ratio hit its five-year low in Mar2023 of 0x.


How does CONCORD BIOTECH 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Book ValuePB RatioMarket Cap
CONCORD BIOTECH 1,812.7211.8921,550.2
SUN PHARMACEUTICAL INDUSTRIES LTD72,218.005.60404,768.0
DIVIS LABORATORIES LTD14,969.0011.92178,468.0
CIPLA LTD31,193.403.89121,326.0
TORRENT PHARMACEUTICALS LTD7,591.2314.54110,345.0
DR REDDYS LABORATORIES LTD33,549.603.39113,757.0
MANKIND PHARMA LTD14,332.406.8798,512.2
ZYDUS LIFESCIENCES LTD23,953.104.1198,470.1
LUPIN LTD17,203.505.3792,350.7
AUROBINDO PHARMA LTD32,653.302.0567,082.6
ABBOTT INDIA LTD4,233.1515.8066,883.0

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CONCORD BIOTECH 's P/B Ratio

Top 10 Industry PeersPB Ratio
Min industry PB 2.05x
Max industry PB 15.80x
Median industry PB 5.60x
Average industry PB 7.77x



You may also like the below Video Courses